Insiders · Profile

Saik Andrew

Chief Financial Officer at ARVINAS · Chief Financial Officer at Yarrow Bioscience. Filing since 8 Sep 2020. CIK 0001616284

Company
Date
Role
Action
Shares
Amount
Of holding
24 Jun 2026
Chief Financial Officer
Sold on a plan
5,696
$46.47K
2.9%
11 May 2026
Chief Financial Officer
Sold at will
11,139
$110.69K
5.5%
13 Feb 2026
Chief Financial Officer
Sold at will
5,134
$61.04K
3.1%
24 Jun 2025
Chief Financial Officer
Sold at will
5,700
$43.38K
3.4%
8 Sep 2020
Chief Financial Officer
Bought
40,000
$58.48K
13.3%
5 decisions on file.